Pdl Biopharma Inc (PDLI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2016 | 09-2016 | 06-2016 | 03-2016 | 12-2015 | |
| Sales | 66,492 | 53,638 | 21,047 | 103,124 | 178,058 |
| Gross Profit | 62,427 | 53,638 | 21,047 | 103,124 | 178,058 |
| Operating Expenses | 74,160 | 20,983 | 9,910 | 9,846 | 16,524 |
| Operating Income | -7,668 | 32,655 | 11,137 | 93,278 | 161,534 |
| Interest Expense | 4,743 | 4,513 | 4,461 | 4,550 | 5,349 |
| Other Income | -2,169 | 162 | 129 | 113 | 6,524 |
| Pre-tax Income | -14,580 | 28,304 | 6,805 | 88,841 | 162,709 |
| Income Tax | -4,300 | 14,400 | 2,657 | 32,954 | 62,135 |
| Net Income Continuous | -10,280 | 13,904 | 4,148 | 55,887 | 100,574 |
| Minority Interests | 56 | -3 | N/A | N/A | N/A |
| Net Income | $-10,336 | $13,907 | $4,148 | $55,887 | $100,574 |
| EPS Basic Total Ops | -0.06 | 0.08 | 0.03 | 0.34 | 0.62 |
| EPS Basic Continuous Ops | -0.06 | 0.08 | 0.03 | 0.34 | 0.61 |
| EPS Diluted Total Ops | -0.06 | 0.08 | 0.03 | 0.34 | 0.64 |
| EPS Diluted Continuous Ops | -0.06 | 0.08 | 0.03 | 0.34 | 0.64 |
| EBITDA(a) | $2,290 | $40,720 | $12,699 | $95,748 | $164,764 |